乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Meeting Coverage >

ASTRO

<乌鸦传媒>Concurrent Boost During Hypofractionated RT Proves Its Worth in Early Breast Cancer

Reduces treatment time, noninferior to conventional RT with sequential boost after lumpectomy

<乌鸦传媒>Radiation for Asymptomatic Bone Metastases May Improve Cancer Survival

Fewer skeletal events, less pain unexpectedly followed by longer life

<乌鸦传媒>Sexual Health Not Part of Discussion for Women Undergoing Brachytherapy

Much less likely than men to be queried about sexual function when receiving treatment

<乌鸦传媒>Shorter Course of Radiation Therapy Proves Mettle in High-Risk Prostate Cancer

Hypofractionation matches standard RT for survival and toxicity in a third less time

<乌鸦传媒>Low Rates of PSA Screening Linked to Increase in Metastatic Prostate Cancer

Will USPSTF's 2018 guidelines reverse this trend?

<乌鸦传媒>New Standard-of-Care Therapy for Advanced Liver Cancer

Stereotactic body radiotherapy plus sorafenib improves survival versus targeted drug alone

<乌鸦传媒>Rapid Radiotherapy Technique Shows Promise in First Human Trial

FLASH relieved pain in most patients with bone metastases, with few side effects

<乌鸦传媒>High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOL

Patients report better urinary and bowel function outcomes

<乌鸦传媒>Tumor Volume-Adapted RT Leads to Good Lung Cancer Control With Low Toxicity

No recurrence at 1 year in 90% of cases with primary tumors, metastases, synchronous disease

<乌鸦传媒>Primary RT Fares Well in Abbreviated Trial for HPV Oropharyngeal Cancer

No deaths, progression with RT after early termination because of deaths in surgery arm

<乌鸦传媒>Mixed Results With RT Plus Short-Term ADT in Intermediate-Risk Prostate Cancer

No survival benefit, but risk of biochemical failure, metastasis, cancer death improved

<乌鸦传媒>Meta-Analysis Reaffirms Role of ADT With Radiotherapy in Prostate Cancer

Prolonged adjuvant ADT also improved survival

<乌鸦传媒>Extended-Field RT Boosts Survival in Locally Advanced Cervical Cancer

Double-digit improvements in OS, DFS, extrapelvic control in well-selected patients

<乌鸦传媒>Gentler Adjuvant RT Could Be Viable for Some HPV-Positive Oral Cancers

Those with extranodal extension didn't fare as well

<乌鸦传媒>Gene Test Finds Gradations in High-Risk Prostate Cancer

Study of untreated cancers prognostic for metastasis, cancer mortality, overall survival

<乌鸦传媒>No Survival Benefit for Internal Mammary Node Irradiation in Breast Cancer

Women with medially or centrally located tumors may be candidates, however, says researcher

<乌鸦传媒>Potential New Standard for Post-Prostatectomy Radiotherapy

Side effects at 2 years similar with hypofractionated versus conventional RT

<乌鸦传媒>Targeted RT Boosts PFS in Oligoprogressive Lung Cancer

Fivefold improvement in NSCLC but no benefit in oligoprogressive breast cancer

<乌鸦传媒>More Evidence for Safety of Accelerated Radiation in Early Breast Cancer

Studies show low toxicity with few recurrences

<乌鸦传媒>Focal RT Boost in High-Risk Prostate Cancer Cuts PSA Relapse

Rates of biochemical relapse cut in half with boost to 95 Gy

<乌鸦传媒>High-Dose SBRT More Effective for Painful Spine Metastases

Roughly one-third of patients had a complete pain response at 3 and 6 months

<乌鸦传媒>ASTRO Unveils First RT Guideline for Pancreatic Cancer

Radiation's role in pancreatic cancer is "controversial," says guideline author

<乌鸦传媒>Tx Deintensification Wins in Head and Neck Cancer, But ...

Only against another less-intensive approach in HPV-positive disease

<乌鸦传媒>Post-Immunotherapy SBRT Boosts Outcomes in Advanced NSCLC

Increased systemic response rate, disease control rate, and PFS in phase II trial

<乌鸦传媒>Consider PSA Before Adding ADT to Salvage Radiation

Men with levels below 0.6 ng/mL show no benefit, at risk of other-cause mortality

<乌鸦传媒>Hippocampus-Sparing Radiation a New Option in Brain Mets Patients

Approach preserved cognitive function, but patient prognosis a key consideration

<乌鸦传媒>Black Race Not Associated with Worse Prostate Ca Outcomes

Results contrast with past population registry data

<乌鸦传媒>SABR Equally Effective in RCC Patients With One or Both Kidneys

Minimal side effects reported with high-dose treatment

<乌鸦传媒>Cetuximab Fails Twice vs Cisplatin for HPV-Related Oral Ca

Cetuximab resulted in more patient deaths across U.S., German studies

<乌鸦传媒>Liquid Biopsy Rules Out Relapse in HPV-Positive Oral Ca

Test had 100% negative predictive value

<乌鸦传媒>Nearly 90% Free of Prostate Ca Progression With ADT, Pelvic Node RT

Data also showed trend toward reduction in distant metastases

<乌鸦传媒>Aggressive RT, Surgery Doubles OS in NSCLC With Limited Mets

If new drug produced such a response it would make "millions," said expert

<乌鸦传媒>No Increase in Late Effects With Weekly RT in Breast Ca

10-year data show low rate of late-onset effects with 28.5 Gy regimen

<乌鸦传媒>RT Add-On Boosts Outcomes in 'Low-Risk' DCIS Breast Ca

Highest benefit seen in patients who also used tamoxifen

<乌鸦传媒>SBRT Doubles 5-Year Survival in Oligometastatic Cancers

Most patients in phase II trial had up to three metastatic lesions